Clinical trials
Active, not recruiting Overweight trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 16 |
| 2024 | 15 |
| 2025 | 41 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 119 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 18 |
| University of Colorado, Denver | 8 |
| Amgen | 5 |
| Novo Nordisk A/S | 5 |
| Pfizer | 5 |
| Kailera | 3 |
| University of Alabama at Birmingham | 3 |
| Brigham and Women's Hospital | 2 |
| Clinical Nutrition Research Center, Illinois Institute of Technology | 2 |
| Johns Hopkins University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 119 |
| Obesity | 109 |
| Weight Loss | 14 |
| Diabetes Mellitus, Type 2 | 13 |
| Hypertension | 10 |
| Diabetes Mellitus | 9 |
| Insulin Resistance | 7 |
| Body Weight | 6 |
| Metabolic Syndrome | 5 |
| Breast Neoplasms | 4 |
Trials
Showing 1 to 25 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.